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The dermonecrotic toxins from Pasteurella multocida (PMT), Bordetella (DNT), Escherichia
coli (CNF1-3), and Yersinia (CNFY) modulate their G-protein targets through deamidation
and/or transglutamination of an active site Gln residue, which results in activation of the
G protein and its cognate downstream signaling pathways. Whereas DNT and the CNFs
act on small Rho GTPases, PMT acts on the α subunit of heterotrimeric Gq, Gi, and
G12/13 proteins. We previously demonstrated that PMT potently blocks adipogenesis and
adipocyte differentiation in a calcineurin-independent manner through downregulation of
Notch1 and stabilization of β-catenin and Pref1/Dlk1, key proteins in signaling pathways
strongly linked to cell fate decisions, including fat and bone development. Here, we
report that similar to PMT, DNT, and CNF1 completely block adipogenesis and adipocyte
differentiation by preventing upregulation of adipocyte markers, PPARγ and C/EBPα, while
stabilizing the expression of Pref1/Dlk1 and β-catenin. We show that the Rho/ROCK
inhibitor Y-27632 prevented or reversed these toxin-mediated effects, strongly supporting
a role for Rho/ROCK signaling in dermonecrotic toxin-mediated inhibition of adipogenesis
and adipocyte differentiation. Toxin treatment was also accompanied by downregulation of
Notch1 expression, although this inhibition was independent of Rho/ROCK signaling. We
further show that PMT-mediated downregulation of Notch1 expression occurs primarily
through G12/13 signaling. Our results reveal new details of the pathways involved in
dermonecrotic toxin action on adipocyte differentiation, and the role of Rho/ROCK
signaling in mediating toxin effects onWnt/β-catenin and Notch1 signaling, and in particular
the role of Gq and G12/13 in mediating PMT effects on Rho/ROCK and Notch1 signaling.
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INTRODUCTION
Members of the dermonecrotic toxin family of large G-protein-
modifying bacterial protein toxins are considered the causative
agents or are associated with the major symptoms of a number
of epizootic and zoonotic diseases (Roop et al., 1987; De Rycke
et al., 1990; Woolfrey andMoody, 1991; Blanco et al., 1992; Foged,
1992; Horiguchi, 2001; Brockmeier et al., 2002; Arashima and
Kumasaka, 2005; Diavatopoulos et al., 2005; Knust and Schmidt,
2010; Wilson and Ho, 2011). The cytotoxic necrotizing factors
from Escherichia coli (CNF1, CNF2, and CNF3) and Yersinia
pseudotuberculosis (CNFY) and the dermonecrotic toxin from
Bordetella spp. (DNT)modify and constitutively activate the small
Rho GTPases, RhoA, Rac1, and Cdc42 (Hoffmann and Schmidt,
2004; Knust and Schmidt, 2010), leading to actin cytoskeletal
rearrangements and changes in cell morphology. CNF1, CNF2,
and CNF3 deamidate a specific Gln residue at the active site
of the Rho GTPases, RhoA (Gln63), Rac1 (Gln61), and Cdc42
(Gln61) (Hoffmann and Schmidt, 2004; Knust and Schmidt,
2010), while CNFY acts only on RhoA (Gln63) (Hoffmann et al.,
2004). Although DNT can modify the same Gln residue on each
of these G proteins through deamidation, it does so primarily
through transglutamination (Schmidt et al., 1999, 2001). The der-
monecrotic toxin from Pasteurella multocida (PMT) also activates
small Rho GTPases (Ohnishi et al., 1998; Orth et al., 2005), but
only indirectly through deamidation of analogous active site Gln
residues in the α subunits of its target heterotrimeric G proteins,
Gi (Gln205), Gq (Gln209), or G12/13 (Gln229) (Orth et al., 2005,
2009; Kamitani et al., 2011; Wilson and Ho, 2011). Remarkably,
although all of the dermonecrotic toxins are deamidases and
DNT and the CNFs share strong sequence similarity in their
catalytic domains, PMT does not have any sequence or struc-
tural similarity with DNT or the CNFs (Wilson and Ho, 2010,
2011).
Bone resorption and subsequent atrophic rhinitis are char-
acteristic outcomes attributed to the actions of PMT and
DNT on differentiation and/or proliferation of osteoblasts and
osteoclasts during respiratory infections in animals with their
respective bacterial pathogens (Ackermann et al., 1995, 1996;
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Sterner-Kock et al., 1995; Gwaltney et al., 1997; Mullan and Lax,
1998; Brockmeier et al., 2002; Harmey et al., 2004; Hildebrand
et al., 2010). Since bone-forming osteoblasts and marrow
adipocytes share a common mesenchymal stem cell origin, it
is anticipated that these dermonecrotic toxins might also affect
adipocyte differentiation. Indeed, there is some evidence that
PMT exposure results in reduced body weight and fat in experi-
mental animals (Cheville and Rimler, 1989; Thurston et al., 1992;
Ackermann et al., 1995, 1996). In support of this, we previously
demonstrated that PMT treatment prevents adipocyte differenti-
ation and blocks adipogenesis in cultured 3T3-L1 cells (Aminova
and Wilson, 2007). We showed that PMT prevented expression
of key adipocyte-specific markers, C/EBPα and PPARγ, in 3T3-
L1 preadipocytes and downregulated these markers in mature
adipocytes. We also showed that PMT prevented the downreg-
ulation of Pref1 (also called Dlk1), an EGF-like transmembrane
protein that is highly expressed in certain tumors and carcino-
mas (Huang et al., 2007; Dezso et al., 2008; Jin et al., 2008;
Yanai et al., 2010; Xu et al., 2012) and that is strongly down-
regulated in adipocytes (Boney et al., 1996; Garces et al., 1999;
Sul, 2009). We further showed that PMT completely downreg-
ulates Notch1 mRNA and protein expression, while stabilizing
β-catenin protein levels (Aminova andWilson, 2007). Notch1 and
Wnt/β-catenin signaling pathways are involved in pivotal cell fate
decisions (Andersson et al., 2011).
Gq-PLCβ1 activation of calcium signaling is known to
block adipogenesis through activation of Ca2+-calmodulin-
dependent calcineurin signaling (Neal and Clipstone, 2002; Liu
and Clipstone, 2007). However, we previously found that the
inhibitory effects of PMT on adipocyte differentiation and
Notch1 could not be reversed by treatment with the calcineurin
inhibitor cyclosporine A (CsA) (Aminova and Wilson, 2007),
suggesting that PMT-induced Gq-PLCβ1 activation of calcium
signaling is not the only signaling pathway mediated by PMT
to block adipocyte differentiation. Although the connection
between G-protein signaling and Notch1 signaling in adipoge-
nesis is not fully understood, we considered the possibility that
PMT-mediated blockade of adipocyte differentiation and adipo-
genesis might occur through its indirect action on Rho-GTPases
through other heterotrimeric G proteins, such as G12/13. To
explore this possibility, we first examined whether the other der-
monecrotic toxins, DNT and CNF1, which directly modify and
activate Rho-GTPases and do not act on heterotrimeric G pro-
teins, might also inhibit 3T3-L1 differentiation and adipogenesis,
and if so, whether theymodulate Notch1 and β-catenin levels sim-
ilar to PMT. Two isoforms of Rho-associated kinases (ROCK1 and
ROCK2) mediate downstream signaling of Rho proteins, leading
to actin reorganization, formation of actin filaments and focal
adhesions, and contractility (Amano et al., 2010). Since inhibition
of ROCK signaling is known to enhance adipogenesis (Noguchi
et al., 2007), we examined whether inhibition of Rho/ROCK sig-
naling might counteract the toxin-mediated effects on 3T3-L1
cells.
Herein, we report that similar to PMT, both DNT and
CNF1 completely block adipogenesis and adipocyte differentia-
tion by preventing expression of PPARγ and C/EBPα, maintain-
ing expression of Pref1/Dlk1 and β-catenin, and downregulating
expression of Notch1. We also show that the Rho/ROCK inhibitor
Y-27632 prevented or reversed these toxin-mediated effects and
that PMT-mediated downregulation of Notch1 occurs primarily
through G12/13 signaling.
MATERIALS ANDMETHODS
RECOMBINANT TOXINS
The pQE-CNF1 vector was provided kindly from Dr. Alison
D. O’Brian at the Uniformed Services University (Mills et al.,
2000). The pTHB-DNT vector was constructed by subcloning
the DNT gene into the BamHI and KpnI sites the expression
vector pTrcHisB (Invitrogen). The DNT gene was generated by
PCR and subcloning using two overlapping DNT gene fragments
from plasmids pDNT103 and pDNT115, kindly obtained from
Dr. Alison A. Weiss at the University of Cincinnati (Walker and
Weiss, 1994). His6-tagged recombinant toxin proteins (rCNF1,
rDNT, and rPMT) were purified using methods essentially as
previously described for rPMT (Aminova and Wilson, 2007),
except rCNF1 and rDNT were expressed in Escherichia coli XL1-
Blue cells under the induction of IPTG. Toxin concentrations
were determined by NIH Image J digital image analysis of Pierce
GelCode Blue-stained SDS-PAGE gels, using BSA as the standard.
The toxins were stored at −80◦C until use. Biological activity
of rPMT, rDNT, and rCNF were confirmed by cell morphol-
ogy assay, as previously described for rPMT (Wilson et al., 2000;
Repella et al., 2011), and by NFAT-luciferase activation assay, as
previously described for rPMT (Aminova et al., 2008).
CELL CULTURE
Murine 3T3-L1 preadipocytes (ATCC, CL-173) were main-
tained at 37◦C and 5% carbon dioxide in normal 10% fetal
bovine serum (FBS, Atlanta Biologicals)-medium, consisting of
Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen) sup-
plemented with 10% heat-inactivated FBS, pH 7.4, 100 units/mL
penicillin G, and 100μg/mL streptomycin.
FLUORESCENCEMICROSCOPY
3T3-L1 cells were treated overnight with the indicated amount
of toxins in the presence or absence of 10μM ROCK inhibitor,
Y-27632 (Sigma, cat #Y0503). Cells were then washed three times
with 1x phosphate buffered saline (PBS) and treated with 0.5%
formaldehyde for 15min. Cells were washed three times with
PBS, treated with 0.1% Triton X-100, washed again with PBS
and treated with TRITC-phalloidin (Sigma, cat #P1951) to stain
F-actin and DAPI (Sigma, cat #D9564) to stain nuclei before
washing and visualizing by fluorescence microscopy. Images were
taken using an Olympus IX-70 inverted fluorescence microscope
equipped with a digital camera (Olympus DP70).
3T3-L1 CELL DIFFERENTIATION
Differentiation studies using 3T3-L1 cells were done essentially
as previously described with slight modification (Aminova and
Wilson, 2007). In brief, 3T3-L1 cells were plated onto a 6-well
plate and grown for 5–6 days until confluence, changing the
medium every 2 days. Two days post-confluence, denoted as
day 0, the cells were induced to differentiate in the presence
or absence of 1 nM of the indicated toxin in normal 10%
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FBS-DMEM or in differentiation medium (DM), consisting of
normal 10% FBS-DMEM with 1μM dexamethasone (Sigma,
cat #D2915), 0.5mM 3-isobutyl-1-methylxanthine (Sigma, cat
#I5879), and 10μg/mL of bovine insulin (Sigma, cat #I6634). Two
days after differentiation induction, the medium was changed to
post-DM, consisting of normal 10% FBS-DMEM with 10μg/mL
of insulin. In the case of experiments involving treatment with
ROCK inhibitor, Y-27632, cells were induced to differentiate in
the presence or absence of 10μM Y-27632 and 1 nM of the indi-
cated toxin. Toxins were removed on day 2, but Y-27632 was
maintained throughout the differentiation process.
OIL RED O STAINING AND LIPID QUANTIFICATION
Accumulation of oil droplets during adipogenesis was visual-
ized by Oil Red O staining, as previously described (Aminova
andWilson, 2007). Phase-contrast microscopy images were taken
using an Olympus IX-70 inverted microscope equipped with a
digital camera (Olympus DP70). Lipid accumulation was mea-
sured by absorbance at 490 nm using a microplate reader (BioTek
Synergy HT). In the case of toxin dose experiments, the read-
ing for oil accumulation was expressed as a percentage of that
observed for fully differentiated cells. The experiments were
repeated at least three times.
IMMUNOBLOTTING
3T3-L1 cells were washed with cold PBS and lysed by incuba-
tion in lysis buffer [50mM Tris-HCl, pH 7.0, containing 1%
SDS, 10% glycerol, 2mM Na3VO4, 2mM EGTA, and a protease
inhibitor cocktail (Sigma, cat#P8340) with benzonase (Sigma,
cat#E8263)]. After 20min of incubation on ice, cell lysates were
centrifuged at 12,000× g for 10min at 4◦C. Total protein con-
centrations were determined by using Bio-Rad Protein Assay
reagent (Bio-Rad). Proteins were separated by SDS-PAGE, trans-
ferred to PVDFmembrane (Osmonics), and analyzed by Western
blot, using standard procedures. Primary antibodies were used
against the following: Pref1/Dlk1 (#AB3511) fromChemicon Int.;
PPARγ (sc-7196), C/EBPα (sc-61), β-catenin (sc-7963), β-actin
(sc-4777), and Notch1 (sc-6015) from Santa Cruz Biotechnology.
Specific protein bands were visualized by the ECL Plus System
(Amersham) using HRP-conjugated secondary antibodies (Santa
Cruz Biotechnology or Sigma). β-actin was used as internal pro-
tein loading controls. However, when comparing treatments in
differentiated and undifferentiated cells, there are no ideal con-
trols for protein levels due to the inherent changes in cellular
protein levels associated with proliferation/differentiation that
occur in response to treatments. For this reason, in cases of toxin
treatments of differentiated adipocytes, where levels of house-
keeping genes such as β-actin significantly change in response to
treatment, each experimental treatment was compared pairwise
without or with treatment and the total protein content of each
sample was first analyzed by Coomassie staining to normalize for
loading.
shRNA KNOCKDOWN
Short hairpin RNAs (shRNAs), corresponding to the Gα and
GFP genes were designed according to the manufacturer’s
instructions. Target sequences for shRNA against Gαq: 5′-GGAA
GCCCGGAGGATCAAC-3′ ; Gα12: 5′-GCGACACCATCTTCGAC
AACA-3′; Gα13: 5′-TGGGTGAGTCTGTAAAGTATT-3′; and
GFP: 5′-GCAAGCTGACCCTGAAGTTC-3′. shRNAswere cloned
into the pSuperRetro vector (OligoEngine, WA) under the con-
trol of polymerase-III H1-RNA gene promoter. Oligonucleotides
were annealed and cloned into the BglII/HindIII site of the vector.
The MLV-based viruses were generated by tripartite transfection
of HEK-293T cells using packing plasmids from Harvard Gene
Therapy Initiative, Boston. Virus titer was estimated by quanti-
fying the number of HEK-293T cells surviving after incubation
in medium containing puromycin (4μg/mL; Sigma, cat#P8833).
3T3-L1 cells, maintained as above, were plated onto 12-well
plates at the density of 5 × 104 cells/mL for 16 h. Cells were then
infected with retroviruses at a titer of 109/mL in the presence of
4μg/mL Polybrene (Sigma, cat#AL-118) at an MOI of 10 and,
after incubation for 24 h virus-infected cells were selected by
treatment for at least 1 week with puromycin (4μg/mL).
RT-PCR
3T3-L1 cells in 60mm culture dishes were treated as described
above. Total RNA was prepared using RNeasy Miniprep Kit
(Qiagen). Total RNA was quantified using a Genesys 2 UV-Vis
spectrophotometer (Spectronics), and samples were stored
at −80◦C until analysis. The levels of mRNA expression were
determined by RT-PCR using Reverse-iT RT-PCR kit (ABgene).
Reverse transcription was performed at 55◦C for 30min, fol-
lowed by PCR in the same tube. To determine the linear range of
cycle numbers for each primer set, RT-PCR was performed with
different RNA amounts from untreated cells at day 0 (for genes
with maximum expression level in preadipocytes) and in mature
adipocytes at day 7 (no treatment with the toxin). RT-PCR
products were analyzed using ethidium bromide-stained agarose
gel electrophoresis. The mRNA expression levels of Notch1 and
the housekeeping gene for GAPDH were determined by using
published primer sets (Garces et al., 1997). ThemRNA expression
levels of Gαq, Gα11, Gα12, and Gα13 were determined by using
the following primer sets: Gαq: forward-AGGCTCATGCACAAT
TGGTTCG, reverse-GATAGGAAGGGTCGGCTACACG; Gα11:
forward-GGCCAATGCACTCCTGATCCG, reverse-GGTAGCCT
ACTGTGGCGATG; Gα12: forward-CGGCTGGTCAAGATCC
TGCT, reverse-AGAGTGCTGCCAGGGAATGC; Gα13: forward-
TCCGTGCTGTCCGTGTGCTT, reverse-GGTTTTTGTTATCT
CCCCAGGG.
STATISTICS
All data shown are representative of at least three independent
experiments performed in triplicate and are presented as the
mean ± standard deviation. Comparisons between groups were
made using the Student’s paired t-test (Excel statistics package),
where statistical significance was defined as P < 0.05.
RESULTS
EFFECT OF TOXINS ONMURINE 3T3-L1 CELL MORPHOLOGY AND
STRESS FIBER FORMATION
Undifferentiated murine 3T3-L1 preadipocytes treated with
0.5 nM rPMT or rDNT formed a dense monolayer with cells clus-
tering into discrete patches or “foci” (Figure 1A), similar to what
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FIGURE 1 | Effect of dermonecrotic toxins on 3T3-L1 preadipocyte cell
morphology and stress fiber formation. (A) Phase-contrast images of
confluent, undifferentiated 3T3-L1 cell monolayers treated continuously for
5 dayswith 0.5 nM of the indicated toxin. (B) Fluorescencemicroscopy images
of undifferentiated 3T3-L1 cells treated for 16h with 1nM of the indicated
toxin in the absence (top panels) or presence (bottom panels) of 10μM
Y-27632. Red, TRITC-phalloidin staining of F-actin, showing stress fibers
resulting from toxin treatment. Blue, DAPI staining of cell nuclei. Bar, 50μm.
was reported before for rPMT-treated or rDNT-treated fibroblasts
(Horiguchi et al., 1995, 1997; Dudet et al., 1996; Lacerda et al.,
1996; Wilson et al., 2000; Aminova and Wilson, 2007). rCNF1-
treated 3T3-L1 cells, on the other hand, showed cell spreading and
enlargement with multi-nucleation but without proliferation,
similar to what was reported before for rCNF1-treated fibroblasts
(Falzano et al., 1993; Fiorentini et al., 1997). These changes were
accompanied in each case by increased formation of actin stress
fibers (Figure 1B, upper panel), similar to that reported previ-
ously (Falzano et al., 1993; Horiguchi et al., 1995, 1997; Dudet
et al., 1996; Lacerda et al., 1996; Fiorentini et al., 1997; Wilson
et al., 2000; Aminova and Wilson, 2007). However, formation of
stress fibers was blocked when cells were treated with toxin in the
presence of the Rho-associated protein kinase (ROCK) inhibitor,
Y-27632 (Figure 1B, lower panel).
EFFECT OF TOXINS ON 3T3-L1 DIFFERENTIATION AND ADIPOGENESIS
3T3-L1 cell differentiation was induced in the absence or pres-
ence of 0.5 nM of rPMT, rDNT, or rCNF1. Lipid accumula-
tion was visualized 7 days after induction of differentiation
by Oil Red O staining of the lipid droplets. As shown in
Figure 2A, after induction of differentiation, 3T3-L1 cells devel-
oped into round adipocytes containing abundant lipid droplets
that stained red (control). In contrast, 3T3-L1 cells treated with
rPMT, rDNT, or rCNF1 at the time of differentiation induction,
failed to differentiate into adipocytes, similar to and in agree-
ment with what was reported previously for PMT (Aminova
and Wilson, 2007). Instead, in all three cases the cells formed
a dense monolayer with little (≤20%) accumulation of lipid
(Figure 2B). This inhibition of adipogenesis was dose-dependent
(Figure 2C), with DNT and CNF1 effecting 70–80% inhibition at
50 pM, while PMT was more potent showing>80% inhibition at
10 pM.
EFFECT OF ROCK INHIBITOR Y-27632 ON TOXIN-MEDIATED
BLOCKADE OF ADIPOGENESIS
To determine whether toxin-mediated inhibition of adipogene-
sis could be rescued by inhibiting Rho/ROCK signaling, 3T3-L1
cells were treated with Y-27632 in the presence of toxins. Y-27632
co-treatment resulted in partial override of the toxin-mediated
blockade of differentiation and lipid accumulation for the case of
rPMT and rDNT (30 and 53%, respectively) and a 76% override
in the case of rCNF1 (Figures 2A,B), even at toxin concentrations
up to 100-fold higher than needed to block adipogenesis.
EFFECT OF TOXINS ON ADIPOGENESISMARKER EXPRESSION
DURING 3T3-L1 DIFFERENTIATION
Protein expression patterns of adipogenesis markers were moni-
tored over the course of 3T3-L1 differentiation in the presence or
absence of 1 nM of rPMT, rDNT, or rCNF1. As expected during
normal differentiation (Figure 3A, far left panels), preadipocytes
exhibited high levels of Pref1/Dlk1 protein expression at the onset
of differentiation induction, but Pref1/Dlk1 levels were absent by
day 4 and remained undetectable in mature adipocytes. PPARγ
and C/EBPα protein expression levels, on the other hand, were
upregulated by day 4 and remained high in mature adipocytes.
In contrast, while Pref1/Dlk1 protein levels decreased by about
half on day 2, similar to the control, in the presence of any of
the toxins the levels were restored by day 4 and were maintained
high thereafter (Figure 3A, right panels). Toxin treatment com-
pletely blocked induction of protein expression of the two major
adipocyte markers, PPARγ and C/EBPα.
EFFECT OF ROCK INHIBITOR Y-27632 ON TOXIN-MEDIATED
BLOCKADE OF ADIPOGENESIS
Since Y-27632 treatment appeared to counteract the toxin-
mediated blockade of adipogenesis (Figure 2), we next examined
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FIGURE 2 | Blockade of 3T3-L1 cell differentiation and lipid accumulation
by dermonecrotic toxins. Confluent 3T3-L1 cells were induced to
differentiate in DM in the absence or presence of 0.5 nM of the indicated
toxin, as described in Materials and Methods. (A) Phase-contrast images of
Oil Red O-stained 3T3-L1 cells on day 7 after induction of differentiation in the
absence (top panels) or presence (bottom panels) of 10μM Y-27632. Bar,
200μm. Red color indicates Oil Red O staining of lipid droplets. Below each
panel are macro-view light images of corresponding Oil Red O-stained
3T3-L1 monolayers on tissue culture plates. (B) Quantification of lipid
accumulation based on Oil Red O staining on day 7 for the indicated toxins,
measured as described in Materials and Methods. White bar, without
Y-27632; black bar, with Y-27632; P < 0.01. (C) Toxin dose-response of lipid
accumulation based on Oil Red O staining. White bar, PMT; gray bar, DNT;
black bar, CNF1; P < 0.01.
whether inhibition of Rho/ROCK signaling could over-
come toxin-mediated downregulation of adipocyte markers,
PPARγ and C/EBPα, upon differentiation induction in 3T3-L1
preadipocytes. As shown in Figure 3B, Y-27632 was able to
partially prevent the downregulation of PPARγ and C/EBPα
by all three toxins, but more so in the case of CNF1. Y-27632
was also able to dampen the toxin-mediated upregulation of
Pref1/Dlk1 in all cases, although again more so for CNF1 than
PMT or DNT. In contrast, Y-27632 was not able to counteract
the downregulation of PPARγ and C/EBPα levels by any of the
toxins in mature adipocytes (Figure 3C).
EFFECTS OF TOXINS ON NOTCH1 AND β-CATENIN SIGNALING
IN 3T3-L1 CELLS
We previously showed that PMT downregulated Notch1 expres-
sion, whilemaintaining Pref1/Dlk1 and β-catenin levels in 3T3-L1
cells during differentiation (Aminova andWilson, 2007). We next
determined whether a similar effect might be observed for the
other dermonecrotic toxins, DNT and CNF1. In control cells,
both Pref1/Dlk1 and β-catenin levels declined during differentia-
tion, while as was previously observed for PMT, β-catenin protein
levels were maintained through day 7 of differentiation in the
presence of either of the other toxins (Figure 3B). For each of
the toxins, Y-27632 partially blocked the effect of the toxins on
β-catenin levels.
In undifferentiated 3T3-L1 preadipocytes, Notch1 protein lev-
els decreased after 1 day of treatment with any of the three toxins
(Figure 4A). For PMT and DNT this decrease in protein levels
could be partially prevented by Y-27632, but apparently through a
mechanism independent of toxin action, since Y-27632 treatment
also caused an increase in Notch1 levels in control cells. Y-27632
also caused a partial increase in Notch1 mRNA levels in the
case of PMT and to a lesser extent DNT, but again Y-27632 also
caused a noticeable, presumably independent increase in Notch1
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FIGURE 3 | Effect of dermonecrotic toxins on adipocyte marker
expression profiles during differentiation. Confluent 3T3-L1 preadipocytes
were induced to differentiate in DM, as described in Materials and Methods.
On the indicated days, cell lysates were subjected to SDS-PAGE and
immunoblot analysis using antibodies against β-catenin, Pref1/Dlk1, PPARγ,
C/EBPα, or β-actin. (A) Time-course of differentiation in the absence (control)
or presence of 1 nM of the indicated toxin. (B) Effect of 10μM Y-27632 on
adipocyte marker expression profiles in preadipocytes on day 7 after
differentiation induction in the absence (control) or presence of 1nM of the
indicated toxin. (C) Effect of 10μM Y-27632 on adipocyte marker expression
profiles in mature adipocytes treated on day 7 after differentiation induction
without (control) or with 1 nM of the indicated toxin and analyzed on day 8.
FIGURE 4 | Effect of dermonecrotic toxins on Notch1 signaling in
3T3-L1 cells. Confluent 3T3-L1 preadipocytes were treated for one day
without (control) or with 1 nM of the indicated toxin in the absence or
presence of 10μM Y-27632. (A) Cell lysates were subjected to SDS-PAGE
and immunoblot analysis using antibodies against Notch1 or β-actin (as
control). (B) Cell lysates were analyzed for mRNA levels for Notch1 or
GAPDH (as control) by RT-PCR.
mRNA levels in control cells (Figure 4B). These results sug-
gest that while toxin-mediated modulation of C/EBPα, PPARγ,
Pref1/Dlk1 and β-catenin protein levels occurs through activa-
tion of Rho/ROCK signaling, toxin-mediated downregulation of
Notch1 does not.
INVOLVEMENT OF Gq AND G12/13 IN PMT-MEDIATED
DOWNREGULATION OF NOTCH1 IN 3T3-L1 CELLS
The involvement of Rho/ROCK signaling in dermonecrotic toxin
action on Notch1 and β-catenin signaling and on adipogenesis
was fully in keeping with Rho proteins as direct targets of DNT
and CNF1 (Aktories et al., 2000; Hoffmann and Schmidt, 2004)
and as indirect targets of PMT (Wilson and Ho, 2011). Since PMT
activates Rho proteins indirectly through activation of Gαq or
Gα12/13 signaling (Sagi et al., 2001; Zywietz et al., 2001; Orth et al.,
2005), we next considered which of these pathways was involved
in PMT-mediated downregulation of Notch1. Gαq, Gα12, and
Gα13 were knocked down in 3T3-L1 cells by using shRNA against
each of their respective shRNAs (Figure 5A). Specificity of shRNA
against Gαq was also confirmed by knockdown of Gαq, but not
the closely related Gα11 (Figure 5A). In the absence of PMT,
knockdown of Gαq, Gα12, or Gα13 alone in 3T3-L1 cells had
no effect on Notch1 mRNA levels (Figure 5B), but in all cases
PMT treatment nearly completely downregulated Notch1 mRNA
levels (Figure 5B), suggesting that PMT activates multiple path-
ways to mediate Notch1 mRNA downregulation. PMT treatment
also completely downregulated Notch1 protein levels in 3T3-L1
cells knocked down in Gαq (Figure 5C). Y-27632 only partially
blocked PMT-mediated downregulation of Notch1 in 3T3-L1
cells knocked down in Gαq (Figure 5D), supporting that PMT-
mediated downregulation of Notch1 does not occur through
Rho/ROCK or Gαq signaling. On the other hand, knockdown of
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FIGURE 5 | Involvement of Gαq and Gα12/13-dependent Rho/ROCK
signaling in Notch1 downregulation by PMT in 3T3-L1 cells. (A) 3T3-L1
preadipocytes were infected with viral particles encoding shRNA against Gαq,
Gα12, Gα13, or GFP (as control) and selected with puromycin for 1 week. Cell
lysates were analyzed for mRNA levels for Gαq, Gα11, Gα12, Gα13, or GAPDH
(as control) by RT-PCR. (B) Notch1 mRNA expression levels in 3T3-L1 cells
expressing shRNA against Gαq, Gα12, Gα13, or GFP and then treated without
(control) or with 0.5 nM PMT for 16h and analyzed as in (A). (C) Notch1
protein levels in 3T3-L1 cells expressing shRNA against Gαq, Gα12, Gα13, or
GFP (as control) treated without (control) or with 0.5 nM PMT for 16h. Cell
lysates were subjected to SDS-PAGE and immunoblot analysis using
anti-Notch1 or anti-β-actin (as control) antibody. (D) Notch1 protein levels in
3T3-L1 cells expressing shRNA against Gαq or GFP (as control) treated
without (control) or with 0.5 nM PMT for 16h in the absence or presence of
10μM Y-27632. Cell lysates were subjected to SDS-PAGE and immunoblot
analysis using anti-Notch1 or anti-β-actin (as control) antibody.
Gα12 or Gα13 blocked the downregulation of Notch1 protein lev-
els by PMT (Figure 5C). These results suggested that Gαq was not
the mediator of PMT-downregulation of Notch1, and instead this
occurs through PMT-mediated activation of Gα12 and Gα13.
DISCUSSION
The 3T3-L1 cell line is a well-established in vitro model of
adipocyte differentiation, which is characterized by expression of
adipocyte-specific markers, such as PPARγ and C/EBPα (Rosen
and Spiegelman, 2000; Otto and Lane, 2005), and downreg-
ulation of pre-adipocyte-specific markers, such as Pref1/Dlk1
(Wang et al., 2010). Our data revealed that treatment of 3T3-L1
cells during differentiation with any one of the dermonecrotic
toxins resulted in blockade of adipogenesis, as evidenced by
lack of lipid accumulation. Toxin treatment in all three cases
also inhibited adipocyte differentiation as evidenced by down-
regulation of PPARγ and C/EBPα levels and stabilization of
Pref1. Moreover, the toxin-mediated effects on adipogenesis and
adipocyte differentiation were Rho/ROCK-dependent as treat-
ment with the ROCK inhibitor Y-27632 countered toxin action
by all three toxins. These results point to a pivotal role of
Rho/ROCK signaling in regulation of adipocyte differentia-
tion and adipogenesis. A summary of the adipogenic signaling
pathways involved in dermonecrotic toxin action are depicted
in Figure 6.
DNT and the CNFs act directly on Rho proteins, while PMT
acts on heterotrimeric G proteins that are upstream of the Rho
proteins. Consistent with this, inhibition of Rho/ROCK signaling
was able to prevent 76% of the inhibition by CNF1 and 53% that
of DNT, but to a much lesser extent that of PMT (30%), suggest-
ing that additional pathways mediate the action of PMT. We thus
wanted to determine which of the upstream Gα protein targets of
PMT were responsible for mediating PMT action on Rho/ROCK-
dependent inhibition of adipogenesis. Since several earlier studies
had demonstrated that stimulators of calcium signaling, such as
calcium ionophores, thapsigargin and prostaglandin (PGF2α),
block adipogenesis through activation of calcineurin, which could
be reversed by calcineurin inhibitors (Shi et al., 2000; Neal and
Clipstone, 2002; Liu and Clipstone, 2007), we previously consid-
ered the possibility that PMT-mediated inhibition of adipogenesis
occurs through its known activation of Gq-PLCβ1-dependent
calcium signaling (Aminova and Wilson, 2007). However, from
those studies we determined that inhibition of calcineurin with
CsA did not prevent the PMT-mediated blockade of adipoge-
nesis or the effects of PMT on expression of PPARγ, C/EBPα,
or Pref1 proteins, suggesting that PMT blockade of adipocyte
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FIGURE 6 | Schematic diagram depicting a proposed model of dermonecrotic toxin action on multiple signaling pathways involved in regulating
3T3-L1 adipocyte differentiation and adipogenesis.
differentiation occurs through other pathways in addition to
the Gq-PLC-calcium-calcineurin signaling pathway. The partial
recovery of differentiation observed for PMT in the presence of
Y-27632 in this study supports the notion that Rho/ROCK sig-
naling mediates at least part of the inhibitory effect of PMT on
differentiation.
Wnt/β-catenin and Notch1 signaling pathways are differen-
tially expressed during adipocyte differentiation (Garces et al.,
1997; Bennett et al., 2002; Kawai et al., 2007), with Wnt/β-
catenin levels decreasing and Notch1 levels increasing during
conversion of preadipocytes into adipocytes. Consistent with
the known opposing roles that Wnt/β-catenin and Notch1 sig-
naling pathways play in regulating adipogenesis and with our
previous observations for PMT (Aminova and Wilson, 2007),
treatment with any one of the dermonecrotic toxins maintained
β-catenin levels, while downregulating Notch1. In this study, we
further investigated the role of Rho/ROCK signaling in toxin-
mediated effects on β-catenin andNotch1 levels by using Y-17632.
Although the β-catenin protein levels were maintained through
day 7 of differentiation in the presence of any of the der-
monecrotic toxins, the presence of Y-27632 dampened this effect,
supporting at least a partial role for Rho/ROCK signaling in
maintaining the predifferentiated state. We next explored the
potential role of Rho/ROCK signaling in mediating the toxin-
induced downregulation of Notch1. In agreement with previ-
ously reported findings for PMT (Aminova and Wilson, 2007),
Notch1 protein levels decreased after 1 day of treatment with
any one of the dermonecrotic toxins in undifferentiated 3T3-L1
preadipocytes. This decrease in Notch1 protein levels could be
partially prevented by Y-27632 in the case of PMT and DNT, but
not CNF1. However, this partial recovery of Notch1 expression
apparently occurred through a mechanism independent of toxin
action, since Y-27632 treatment also caused an increase in Notch1
levels in control cells. Similar results were observed for Notch1
mRNA levels in the presence of Y-27632. In all, these results sug-
gest that toxin-mediated Notch1 downregulation does not occur
through activation of Rho/ROCK signaling.
In this study, we further considered the possible involvement
of G12 and/or G13 in mediating PMT downregulation of Notch1.
Results using shRNA-mediated knockdown of Gαq, G12, or G13
confirmed our previous findings that Gαq was not involved and
instead support the involvement of both G12 and G13 in medi-
ating the action of PMT on Notch1. Although we cannot rule
out the possibility that the observed inhibitory action of PMT on
adipocyte differentiation was mediated at least in part through
PMT-activation of Gi signaling, our results with knockdown of
G12 and G13 clearly show that PMT-mediated downregulation
of Notch1 could be attributed almost fully to the presence of
G12 and G13. Our results are also consistent with the connec-
tion between Rho/ROCK signaling and the action of lysophos-
phatidic acid (LPA), a known bioactive phospholipid ligand of
Gi/q/12/13-protein-coupled receptors that activate Rho signaling
(Lee et al., 2007), and suggest that the activation of Rho/ROCK
by LPA might be mediated primarily through G12/13 and not Gq
or Gi signaling. LPA is known to inhibit adipogenesis through
downregulation of PPARγ expression (Simon et al., 2005) and
upregulation of Wnt/β-catenin signaling through activation of
the Rho/ROCK pathway (Li et al., 2011).
Mounting evidence points toward an important, yet thus
far ill-defined role for chronic or previous exposure to bacte-
rial pathogens in cancer predisposition (Lax, 2005; Vogelmann
and Amieva, 2007; Nath et al., 2010) and immune modulation
(Backert and Konig, 2005). In a growing number of instances, the
apparent etiological agent responsible is a toxin, e.g., CagA from
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Helicobacter pylori (Murata-Kamiya, 2011). The cellular actions
of the dermonecrotic toxins, PMT, DNT and the CNFs, have
been implicated as risk factors to cancer predisposition (Lax,
2005; Oswald et al., 2005; Orth et al., 2007; Travaglione et al.,
2008; Wilson and Ho, 2011) due to their effects on Rho-GTPase
signaling pathways involved in cell morphology and motility,
such as cytoskeletal rearrangements and focal adhesion, and on
induction of anti-apoptotic (Bcl-2) and pro-inflammatory (NF-
kB and COX-2) protein expression (Lacerda et al., 1997; Oswald
et al., 2005; Fabbri et al., 2008; Travaglione et al., 2008; Fabbri
et al., 2010). In addition to its effects on cytoskeletal function,
the oncogenic potential of PMT has also been linked to its
strong mitogenic (Erk and p38 MAPK pathways) and/or anti-
apoptotic (JAK/STAT and Akt pathways) signaling activity in a
number of cell types (Lax and Thomas, 2002; Lax, 2005; Oswald
et al., 2005; Orth et al., 2007; Wilson and Ho, 2010, 2011),
including cultured mesenchymal cells, such as mouse, rat, and
human fibroblasts (Wilson et al., 2000; Orth et al., 2007; Ozgen
et al., 2008; Hildebrand et al., 2010), preadipocytes (Aminova
and Wilson, 2007) and osteoblasts (Sterner-Kock et al., 1995;
Mullan and Lax, 1996, 1998; Gwaltney et al., 1997; Harmey et al.,
2004). Wnt/β-catenin, Pref1/Dlk1 and Notch1 signaling pathways
are strongly linked to cancer predisposition (Polakis, 2007; Roy
et al., 2007; Jin et al., 2008), neurological and immunological
dysfunctions (Cheng et al., 2010; Imayoshi et al., 2010; Yuan
et al., 2010), and fat and bone developmental disorders (Prestwich
and Macdougald, 2007; Wagner et al., 2011; Zanotti and Canalis,
2012). Our results describing the dysregulation of β-catenin,
Pref1/Dlk1 and Notch1 protein expression by dermonecrotic tox-
ins further add to the accumulating evidence that exposure to
bacteria that produce these dermonecrotic toxins might predis-
pose those infected individuals to potential long-term adverse
outcomes.
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